Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Osmetech looks for a US marketing partner:

This article was originally published in Clinica

Executive Summary

Osmetech, a UK company developing technology to diagnose disease from analysis of the scent given off, says it has completed clinical trials to detect urinary tract infection and estimates the test could win US FDA approval by the autumn. Osmetech says that it now seeks a large US diagnostics company to commercialise the test. Osmetech has recently appointed a new chief executive, James White, to replace Giap Wang Chong, who now takes a non-executive role. Osmetech saw increased losses for its first six months, up to £2.1 million ($3 million) compared with £1.7 million for the same period last year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069771

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel